R&D Systems™ Recombinant Human IL-23 Protein

Catalog No.	Quantity
12-90I-L500CF	500 μg

Catalog No. 12-90I-L500CF Supplier R&D Systems™ Supplier No. 1290IL500/CF

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Human IL-23 Protein is derived from Sf 21 (baculovirus). The Recombinant Human IL-23 Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: P29460 (p40) and AAG37232(p19)
• Characterization: Bioactivity
• For Use With (Application): Bioactivity
• Formulation: Supplied as a 0.2μm filtered solution in MES, NaCl and EDTA.
• Gene ID (Entrez): 51561
• Molecular Weight (g/mol): 55.0kDa (IL-23 single chain), 36.5kDa (p40), 18.5kDa (p19)
• Quantity: 500 μg
• Source: Spodoptera frugiperda,Sf 21 (baculovirus)-derived human IL-23 protein, (N-terminus) Human IL-23 p40 (Ile23-Ser328) Accession &Num; P29460 GSGSSRGGSGSGGSGGGGSKL Human IL-23 p19 (Arg20-Pro189) Accession &Num; AAG37232 (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after opening. 3 months, -20 to -70° C under sterile conditions after opening.
• Endotoxin Concentration: <1.0EU per 1μg of the protein by the LAL method.
• Gene Symbol: IL23A
• Product Type: Recombinant Protein
• Conjugate: Unconjugated
• Species: Human
• Purity or Quality Grade: >90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.